Arevipharma Overview

  • Year Founded
  • 1873

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 72

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Arevipharma General Information

Description

Manufacturer of generic and pharmaceutical ingredients intended for the global pharmaceutical industry. The company offers buprenorphine, fentanyl, ketamine, bisoprolol fumarate, carbamazepine, and torasemide, providing pharmaceutical clients with current good manufacturing practice-compliant active ingredients and specialized narcotic handling services to support drug development and production.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Meissner Strasse 35
  • 01445 Radebeul
  • Germany
+49 0351
Primary Industry
Pharmaceuticals
Other Industries
Logistics
Other Pharmaceuticals and Biotechnology
Parent Company
Yonsung Fine Chemicals
Vertical(s)
Corporate Office
  • Meissner Strasse 35
  • 01445 Radebeul
  • Germany
+49 0351

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arevipharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Arevipharma‘s full profile, request access.

Request a free trial

Arevipharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of generic and pharmaceutical ingredients intended for the global pharmaceutical industry. The company offe
Pharmaceuticals
Radebeul, Germany
72 As of 2026

Berlin, Germany
 

Madrid, Spain
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Arevipharma Competitors (3)

One of Arevipharma’s 3 competitors is CPL SACHSE, a Corporation company based in Berlin, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CPL SACHSE Corporation Berlin, Germany
Suanfarma Private Equity-Backed Madrid, Spain
Procyon Life Sciences Corporation Mumbai, India
You’re viewing 3 of 3 competitors. Get the full list »

Arevipharma Patents

Arevipharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3238849-A1 Method of making buprenorphine and precursor compounds thereof Pending 16-Dec-2021
EP-4448501-A1 Method of making buprenorphine and precursor compounds thereof Pending 16-Dec-2021
US-20250154160-A1 Method of making buprenorphine and precursor compounds thereof Pending 16-Dec-2021
WO-2023111125-A1 Method of making buprenorphine and precursor compounds thereof Inactive 16-Dec-2021
EP-3617181-A1 Synthesis of trans-2-phenylcyclopropylamine or a salt or solvate thereof Inactive 30-Aug-2018 C07C67/14
To view Arevipharma’s complete patent history, request access »

Arevipharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arevipharma FAQs

  • When was Arevipharma founded?

    Arevipharma was founded in 1873.

  • Where is Arevipharma headquartered?

    Arevipharma is headquartered in Radebeul, Germany.

  • What is the size of Arevipharma?

    Arevipharma has 72 total employees.

  • What industry is Arevipharma in?

    Arevipharma’s primary industry is Pharmaceuticals.

  • Is Arevipharma a private or public company?

    Arevipharma is a Private company.

  • What is Arevipharma’s current revenue?

    The current revenue for Arevipharma is .

  • Who are Arevipharma’s competitors?

    CPL SACHSE, Suanfarma, and Procyon Life Sciences are competitors of Arevipharma.

  • When was Arevipharma acquired?

    Arevipharma was acquired on 01-Jan-2021.

  • Who acquired Arevipharma?

    Arevipharma was acquired by Yonsung Fine Chemicals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process